ADAM CAMPBELL: Open Payments
NPI 1023787082 · SENECA, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$476 in 21 payments from 9 companies in 2025. Trend: 2023 $870 · 2024 $691 · 2025 $476
Food & beverage: $476
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 8 | $167 |
| MERZ NORTH AMERICA, INC. | 1 | $115 |
| PFIZER INC. | 2 | $35 |
| Exact Sciences Corporation | 2 | $33 |
| Novo Nordisk Inc | 2 | $33 |
| Lilly USA, LLC | 2 | $30 |
| ABBVIE INC. | 2 | $30 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $19 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $14 |
Products named: Xeomin, FARXIGA, AIRSUPRA, ELIQUIS, MOUNJARO, QULIPTA, CAPLYTA, Cologuard Collection Kit.
Industry payments across SC — which companies pay providers there.
